anlotinib,sintilimab,talazoparib,berzosertib
sino biopharmaceuticals,advenchen,eli lilly,pfizer,merck
['sclc', 'talazoparib', 'anlotinib', 'berzosertib', 'sintilimab']
. discussing #locally advanced and #sclc posters - focusing on data on sclc berzosertib + topo in n=15, 2 w/ durable response sintilimab + anlotinib 48.7% orr talazoparib + temo also promising #asco22 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | Faculty @PC31 | Associate Director @PennPrecisMed | Tweets my own